These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 8042659

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
    Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB, DMID 08-0006 Tularemia Vaccine Study Group.
    Vaccine; 2017 Aug 24; 35(36):4730-4737. PubMed ID: 28750854
    [Abstract] [Full Text] [Related]

  • 23. Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.
    Kim TH, Pinkham JT, Heninger SJ, Chalabaev S, Kasper DL.
    J Infect Dis; 2012 Apr 01; 205(7):1056-65. PubMed ID: 21969334
    [Abstract] [Full Text] [Related]

  • 24. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
    Jia Q, Bowen R, Dillon BJ, Masleša-Galić S, Chang BT, Kaidi AC, Horwitz MA.
    Sci Rep; 2018 May 03; 8(1):7009. PubMed ID: 29725025
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.
    Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, Blalock LT, Conlan JW, Kasper DL.
    Vaccine; 2009 Jan 22; 27(4):597-605. PubMed ID: 19022323
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
    De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.
    mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322
    [Abstract] [Full Text] [Related]

  • 31. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Sunagar R, Kumar S, Franz BJ, Gosselin EJ.
    Vaccine; 2016 Jun 17; 34(29):3396-404. PubMed ID: 27182819
    [Abstract] [Full Text] [Related]

  • 32. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL.
    Infect Immun; 2007 May 17; 75(5):2591-602. PubMed ID: 17296751
    [Abstract] [Full Text] [Related]

  • 33. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS.
    PLoS One; 2013 May 17; 8(4):e61539. PubMed ID: 23613871
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
    Eyles JE, Hartley MG, Laws TR, Oyston PC, Griffin KF, Titball RW.
    Microb Pathog; 2008 Feb 17; 44(2):164-8. PubMed ID: 17904793
    [Abstract] [Full Text] [Related]

  • 36. Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.
    Alqahtani M, Ma Z, Fantone K, Malik M, Bakshi CS.
    Infect Immun; 2021 Jun 16; 89(7):e0013421. PubMed ID: 33875472
    [Abstract] [Full Text] [Related]

  • 37. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H, Chen W, Conlan JW.
    Vaccine; 2004 Jun 02; 22(17-18):2116-21. PubMed ID: 15149767
    [Abstract] [Full Text] [Related]

  • 38. Francisella tularensis Live Vaccine Strain training of murine alveolar and bone marrow-derived macrophages.
    Khan H, Bhargava V, Elkins KL.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0002824. PubMed ID: 38940590
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.